{
  "actions": [
    {
      "acted_at": "2000-07-27", 
      "references": [
        {
          "reference": "CR S7907-7908", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2000-07-27", 
      "committee": "Committee on the Judiciary", 
      "references": [
        {
          "reference": "CR S7908-7909", 
          "type": "text of measure as introduced"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on the Judiciary.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2993-106", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Judiciary", 
      "committee_id": "SSJU"
    }
  ], 
  "congress": "106", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Kohl, Herb", 
      "sponsored_at": "2000-07-27", 
      "state": "WI", 
      "thomas_id": "01380", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2000-07-27", 
  "number": "2993", 
  "official_title": "A bill to enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Drug Competition Act of 2000", 
  "sponsor": {
    "district": null, 
    "name": "Leahy, Patrick J.", 
    "state": "VT", 
    "thomas_id": "01383", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2000-07-27", 
  "subjects": [
    "Actions and defenses", 
    "Administrative procedure", 
    "Antitrust law", 
    "Commerce", 
    "Drug approvals", 
    "Drug industry", 
    "Federal Trade Commission", 
    "Fines (Penalties)", 
    "Generic drugs", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Independent regulatory commissions", 
    "Injunctions", 
    "Law", 
    "Marketing", 
    "Pharmaceutical research", 
    "Research and development", 
    "Restrictive trade practices", 
    "Science, technology, communications"
  ], 
  "subjects_top_term": "Commerce", 
  "summary": {
    "as": "Introduced", 
    "date": "2000-07-27", 
    "text": "Drug Competition Act of 2000 - Requires brand name drug manufacturers and generic drug manufacturers to file with the Federal Trade Commission and the Attorney General agreements affecting the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Drug Competition Act of 2000", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:42:26-05:00"
}